The Melatonin Adjunct in the Acute myocaRdial Infarction Treated With Angioplasty (MARIA)
This study is currently recruiting participants.
Verified December 2013 by Fundación Canaria Rafael Clavijo para la Investigación Biomédica
Alberto Dominguez-Rodriguez, MD, PhD, FESC
Information provided by (Responsible Party):
Alberto Dominguez-Rodriguez, MD, PhD, FESC, Fundación Canaria Rafael Clavijo para la Investigación Biomédica
First received: March 12, 2008
Last updated: December 30, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||November 2015|
|Estimated Primary Completion Date:||November 2014 (Final data collection date for primary outcome measure)|
Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Kaski JC, Reiter RJ, Jimenez-Sosa A. A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: study design and rationale. Contemp Clin Trials. 2007 Jul;28(4):532-9. Epub 2006 Oct 17.